The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition.
This invention is related to a controlled release composition comprising a cross-linked gelatin and at least one therapeutic protein wherein the ratio of the average mesh size (ξ) of the gelatin matrix and the average hydrodynamic radius (RH) of the therapeutic protein is smaller than 2, preferably smaller than 1.5.
本发明涉及药理学领域。更具体地说,本发明涉及一种控释组合物。
本发明涉及一种由交联明胶和至少一种治疗蛋白质组成的控释组合物,其中明胶基质的平均网眼尺寸(ξ)与治疗蛋白质的平均
水动力半径(RH)之比小于 2,最好小于 1.5。